Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects.

Godlewski, Grzegorz; Alapafuja, Shakiru O; Bátkai, Sándor; Nikas, Spyros P; Cinar, Resat; Offertáler, László; Osei-Hyiaman, Douglas; Liu, Jie; Mukhopadhyay, Bani; Harvey-White, Judith; Tam, Joseph; Pacak, Karel; Blankman, Jacqueline L; Cravatt, Benjamin F; Makriyannis, Alexandros; Kunos, George

Godlewski, Grzegorz; Alapafuja, Shakiru O; Bátkai, Sándor; Nikas, Spyros P; Cinar, Resat; Offertáler, László; Osei-Hyiaman, Douglas; Liu, Jie; Mukhopadhyay, Bani; Harvey-White, Judith; Tam, Joseph; Pacak, Karel; Blankman, Jacqueline L; Cravatt, Benjamin F; Makriyannis, Alexandros; Kunos, George.

Affiliation

Godlewski G; Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Rockville, MD 20852, USA.

Chem Biol ; 17(11): 1256-66, 2010 Nov 24.

Article in En | MEDLINE | ID: mdl-21095576

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenols / Alkanesulfonates / Enzyme Inhibitors / Amidohydrolases / Antihypertensive Agents Limits: Animals Language: En Journal: Chem Biol Journal subject: BIOLOGIA / BIOQUIMICA / QUIMICA Year: 2010 Document type: Article Affiliation country:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google